IP Verse

Glaxosmithkline Intellectual Property Management Limited competitive analysis

Latest oppositions filed by Glaxosmithkline Intellectual Property Management Limited

Explore patent oppositions filed by Glaxosmithkline Intellectual Property Management Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
EP3653221
Anti-Pvrig Antibodies And Methods Of UseCOMPUGENMay 2, 2023
EP3259597
Pvrig Polypeptides And Methods Of TreatmentCOMPUGENJan 5, 2023
EP2997036
Purification Of Recombinantly Produced PolypeptidesMEDIMMUNEDec 3, 2021
EP3616720
Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITYNov 17, 2021
EP3137186
Methods For The Purification Of Proteins Using Caprylic AcidNOVO NORDISKOct 26, 2021
EP3377618
Buffers For Stabilization Of Lentiviral PreparationsNOVARTISAug 12, 2021
EP3294770
Therapeutic And Diagnostic Methods For CancerF HOFFMANN LA ROCHEJul 7, 2021
EP3134095
Improved Methods For Manufacturing Adoptive Cell TherapiesBLUEBIRD BIOJan 21, 2021
EP3303632
Therapeutic And Diagnostic Methods For CancerF HOFFMANN LA ROCHEDec 4, 2020
EP3431105
Medicinal Composition For Treating CancerOSAKA UNIVERSITYSep 30, 2020

Latest PTAB cases involving Glaxosmithkline Intellectual Property Management Limited

Discover the latest PTAB cases involving Glaxosmithkline Intellectual Property Management Limited, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Intellectual Property Management Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED16 - - -
COMPUGEN - 6 - -
F HOFFMANN LA ROCHE16195 - -
GENETHON - 24 - -